Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 28

1.

Gene Expression Profiling for Predicting Outcomes in Stage II Colon Cancer [Internet].

Black ER, Falzon L, Aronson N.

Rockville (MD): Agency for Healthcare Research and Quality (US); 2012 Dec.

2.

Gene expression profiling and expanded immunohistochemistry tests to guide the use of adjuvant chemotherapy in breast cancer management: a systematic review and cost-effectiveness analysis.

Ward S, Scope A, Rafia R, Pandor A, Harnan S, Evans P, Wyld L.

Health Technol Assess. 2013 Oct;17(44):1-302. doi: 10.3310/hta17440. Review.

3.

A systematic overview of chemotherapy effects in colorectal cancer.

Ragnhammar P, Hafström L, Nygren P, Glimelius B; SBU-group. Swedish Council of Technology Assessment in Health Care..

Acta Oncol. 2001;40(2-3):282-308. Review.

PMID:
11441937
4.

Prediction of adjuvant chemotherapy benefit in endocrine responsive, early breast cancer using multigene assays.

Albain KS, Paik S, van't Veer L.

Breast. 2009 Oct;18 Suppl 3:S141-5. doi: 10.1016/S0960-9776(09)70290-5. Review.

PMID:
19914534
5.

American Society of Clinical Oncology recommendations on adjuvant chemotherapy for stage II colon cancer.

Benson AB 3rd, Schrag D, Somerfield MR, Cohen AM, Figueredo AT, Flynn PJ, Krzyzanowska MK, Maroun J, McAllister P, Van Cutsem E, Brouwers M, Charette M, Haller DG.

J Clin Oncol. 2004 Aug 15;22(16):3408-19. Epub 2004 Jun 15. Review.

PMID:
15199089
6.

Gene expression profiles as predictors of poor outcomes in stage II colorectal cancer: A systematic review and meta-analysis.

Lu AT, Salpeter SR, Reeve AE, Eschrich S, Johnston PG, Barrier AJ, Bertucci F, Buckley NS, Salpeter EE, Lin AY.

Clin Colorectal Cancer. 2009 Oct;8(4):207-14. doi: 10.3816/CCC.2009.n.035. Review.

PMID:
19822511
7.

Screening for Cognitive Impairment in Older Adults: An Evidence Update for the U.S. Preventive Services Task Force [Internet].

Lin JS, O'Connor E, Rossom RC, Perdue LA, Burda BU, Thompson M, Eckstrom E.

Rockville (MD): Agency for Healthcare Research and Quality (US); 2013 Nov.

8.

Evolving role of gene expression signatures as biomarkers in early-stage colon cancer.

Goel G.

J Gastrointest Cancer. 2014 Dec;45(4):399-404. doi: 10.1007/s12029-014-9634-7. Review.

PMID:
24989938
9.

Risk of recurrence in patients with colon cancer stage II and III: a systematic review and meta-analysis of recent literature.

Böckelman C, Engelmann BE, Kaprio T, Hansen TF, Glimelius B.

Acta Oncol. 2015 Jan;54(1):5-16. doi: 10.3109/0284186X.2014.975839. Epub 2014 Nov 28. Review.

PMID:
25430983
10.

Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.

Williams C, Brunskill S, Altman D, Briggs A, Campbell H, Clarke M, Glanville J, Gray A, Harris A, Johnston K, Lodge M.

Health Technol Assess. 2006 Sep;10(34):iii-iv, ix-xi, 1-204. Review.

11.

Prognostic and predictive markers in stage II colon cancer: is there a role for gene expression profiling?

Kelley RK, Venook AP.

Clin Colorectal Cancer. 2011 Jun;10(2):73-80. doi: 10.1016/j.clcc.2011.03.001. Epub 2011 Apr 22. Review.

12.

Technology Assessment on Genetic Testing or Molecular Pathology Testing of Cancers with Unknown Primary Site to Determine Origin [Internet].

Meleth S, Whitehead N, Evans TS, Lux L.

Rockville (MD): Agency for Healthcare Research and Quality (US); 2013 Feb 20.

13.

Adjuvant therapy for completely resected stage II colon cancer.

Figueredo A, Coombes ME, Mukherjee S.

Cochrane Database Syst Rev. 2008 Jul 16;(3):CD005390. doi: 10.1002/14651858.CD005390.pub2. Review.

PMID:
18646127
14.

Prognostic and predictive significance of MSI in stages II/III colon cancer.

Saridaki Z, Souglakos J, Georgoulias V.

World J Gastroenterol. 2014 Jun 14;20(22):6809-14. doi: 10.3748/wjg.v20.i22.6809. Review.

15.

Oncotype DX(®) colon cancer assay for prediction of recurrence risk in patients with stage II and III colon cancer: A review of the evidence.

You YN, Rustin RB, Sullivan JD.

Surg Oncol. 2015 Jun;24(2):61-6. doi: 10.1016/j.suronc.2015.02.001. Epub 2015 Feb 14. Review.

PMID:
25770397
16.

Challenges in the management of stage II colon cancer.

Dotan E, Cohen SJ.

Semin Oncol. 2011 Aug;38(4):511-20. doi: 10.1053/j.seminoncol.2011.05.005. Review.

17.

Testing of CYP2C19 Variants and Platelet Reactivity for Guiding Antiplatelet Treatment [Internet].

Dahabreh IJ, Moorthy D, Lamont JL, Chen ML, Kent DM, Lau J.

Rockville (MD): Agency for Healthcare Research and Quality (US); 2013 Sep.

18.

Screening for Skin Cancer in Adults: An Updated Systematic Evidence Review for the U.S. Preventive Services Task Force [Internet].

Wernli KJ, Henrikson NB, Morrison CC, Nguyen M, Pocobelli G, Whitlock EP.

Rockville (MD): Agency for Healthcare Research and Quality (US); 2016 Jul.

19.

Technology Assessment of Molecular Pathology Testing for the Estimation of Prognosis for Common Cancers [Internet].

Meleth S, Reeder-Hayes K, Ashok M, Clark R, Funkhouser W, Wines R, Hill C, Shanahan E, McClure E, Burson K, Coker-Schwimmer M, Garge N, Jonas DE.

Rockville (MD): Agency for Healthcare Research and Quality (US); 2014 May 29.

20.

Enzyme-Replacement Therapies for Lysosomal Storage Diseases [Internet].

Ratko TA, Marbella A, Godfrey S, Aronson N.

Rockville (MD): Agency for Healthcare Research and Quality (US); 2013 Jan.

Supplemental Content

Support Center